FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe
In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients
First Compound From New In Vitro Screening to Enter Clinical Trials
DCBD Board Okays Concept for Animal Holding Recompetition
Minorities Increasingly Involved In Research, Training Programs
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research









